GHDx
Published on GHDx (https://ghdx.healthdata.org)


Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs

General Info

Geography 
Germany (DEU)
Germany, West (DEU) (Germany)
Time period covered 
January, 2001 - December, 2012
Data type
Scientific literature
Keywords 
Liver cancer

Citation

Authors 
Hinrichsen I, Kemp M, Peveling-Oberhag J, Passmann S, Plotz G, Zeuzem S, Brieger A
Journal 
PLoS One
Pages 
e84453
Publication year 
2014
Suggested citation 
Hinrichsen I, Kemp M, Peveling-Oberhag J, Passmann S, Plotz G, Zeuzem S, Brieger A. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs. PLoS One. 2014; 9: e84453.

Source URL:https://ghdx.healthdata.org/record/promoter-methylation-mlh1-pms2-msh2-and-p16-phenomenon-advanced-stage-hccs